Last reviewed · How we verify
NCT04036149
To Compare Postoperative Horizontal Position Stability of the CT LUCIA 611P and the CT ASPHINA 409MP
NA trial testing Intraocular lens in Cataract Senile in 54 participants. Completed in 20 July 2018.
20 July 2018
Quick facts
| Lead sponsor | Carl Zeiss Meditec AG |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 54 |
| Start date | 14 March 2017 |
| Primary completion | 20 July 2018 |
| Estimated completion | 20 July 2018 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Intraocular lens
Conditions studied
- Cataract Senile — all drugs for Cataract Senile →
Sponsor
Carl Zeiss Meditec AG — full company profile →
Who can join
Adults 50 to 90, any sex, with Cataract Senile. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of the trial is to assess the efficacy of the CT LUCIA 611P intraocular lens (IOL) with regard to the horizontal IOL position stability. The horizontal position collected at 1 month and 4 to 6 months post-operatively will be compared to the horizontal IOL position recorded at baseline (1 week post-operatively) as well as to the position stability of the reference IOL, CT ASPHINA 409MP.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04036149
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intraocular lens
Trials testing the same drug.
- NCT05735990 — Retrospective Clinical Investigation of the Safety and Performance of 640PM Trifocal IOL Implantation in Patients With C · completed
- NCT05541796 — Clinical Outcomes Following Implantation of Tecnis Synergy and Symfony Intraocular Lens · NA · completed
- NCT04907500 — Prospective Evaluation of an Hydrophilic Acrylic Intraocular Lens · NA · completed
- NCT06528678 — Patients Outcomes of a Monofocal Intraocular Lens Designed for Monovision · completed
- NCT04175951 — Tecnis Eyhance Versus Rayner RayOne Study · NA · unknown
Other recruiting trials for Cataract Senile
Currently open trials in the same condition.
- NCT04570579 — Impact of a Novel Extended Depth of Focus Intraocular Lens on Visual and Lifestyle Enhancement · active not recruiting
Other Carl Zeiss Meditec AG trials
Trials by the same sponsor.
- NCT07471295 — Toric Performance And Constant Evaluation · Phase 4 · not yet recruiting
- NCT07297719 — Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation · completed
- NCT06192901 — Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses After Bilateral Cataract Surgery · completed
- NCT06247683 — Study to Confirm Safety and Performance of a New Multifocal IOL · NA · completed
- NCT05646004 — 621 Real World Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04036149 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Carl Zeiss Meditec AG
- Last refreshed: 31 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04036149.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing